Research Collaboration Secured to Evaluate AI-Driven Cardiac Risk Stratification in Cancer Patients

Research collaboration with Mayo Clinic to evaluate EIQ's AI platform for cardiac risk stratification in oncology patients Study to assess the ability of Echo IQ's AI technology to evaluate cardiac risk in patients undergoing cancer therapy using routinely acquired echocardiographic data Targets the rapidly emerging cardio-oncology sector, a growing market driven by increasing cancer survival rates and focus on treatment-related cardiovascular complications SYDNEY, Australia, June 12, 2026 (GLOB